Medical Schools Push Back on 'March-In' Rights Plan to Lower Drug Prices

(MedPage Today) -- Key stakeholders from academia and medicine are pushing back on a Biden administration proposal that would leverage "march-in rights" in an effort to rein in unreasonably priced drugs developed with the support of taxpayer dollars...
Source: MedPage Today Public Health - Category: American Health Source Type: news